Company intelligence / Profile preview

Xmark Opportunity Fund

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Xmark Opportunity Fund is a specialized investment vehicle managed by Xmark Management that focuses on the life sciences and healthcare sectors. The fund typically invests in publicly traded and private companies involved in biotechnology, medical devices, and pharmaceutical development. Xmark is known for taking active roles in its portfolio companies, often providing strategic guidance and capital to support clinical development and commercialization efforts. Its investment strategy often targets undervalued healthcare entities with significant intellectual property or late-stage clinical assets.

Industry: Investors

Beyond the preview

Go deeper on Xmark Opportunity Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xmark Opportunity Fund.

Explore the full profile